John Mascarenhas, Andrew Tucker Kuykendall, Terrence J. Bradley, Bart L. Scott, Yiqun Yang, Ashley Lennox, Michelle Mudge-Riley, Judy Ho, Joseph E. Eid, Salman Otoukesh. "Updated protocol: IMPROVEMF, a phase 1b trial of imetelstat (IME)+ ruxolitinib (RUX) in patients (pts) with intermediate (INT)-1/2 or high-risk (HR) myelofibrosis (MF).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps6604